Camp Lejeune Update: $723M Paid, $907M Offered — and Still No Bellwether Trial

The government has now paid out roughly $723 million in Camp Lejeune settlements and extended about $907 million in offers, according to the joint status report filed June 15, 2026 — up from $570.7 million paid and $794.7 million offered just two months earlier. The money is moving faster than at any point since the law passed.

The bottleneck has not moved at all. Of the 408,860 administrative claims filed with the Department of the Navy before the deadline closed, the number resolved remains well under 1%. And nearly four years into the Camp Lejeune Justice Act, not one bellwether case has gone to trial — no jury has valued a single claim, and the litigation track that tens of thousands of claimants are counting on has yet to produce a benchmark.

What Happened at Camp Lejeune

For roughly 34 years between 1953 and 1987, drinking water at the U.S. Marine Corps base at Camp Lejeune, North Carolina was contaminated with industrial solvents — primarily trichloroethylene (TCE), perchloroethylene (PCE), benzene, and vinyl chloride — at concentrations hundreds of times the levels that are now considered safe. Sources included an off-base dry cleaner, on-base fuel storage leaks, and improper disposal of industrial chemicals. Camp Lejeune is the most consequential US military-base water contamination case, but it is not the only one — the Red Hill, Hawaii fuel-leak EPA final report covers the most recent comparable incident.

The figure most often cited is that up to one million people lived or worked on the base during those years — active-duty Marines, their spouses and children, civilian employees, and contractors. That number is worth handling with care: it traces to an assertion made at a 2010 congressional hearing, and neither ATSDR nor the CDC has ever published an official count of the exposed population. A 2009 National Research Council review stated flatly that the number served had not been determined. What is not in dispute is that the water reached barracks, family housing, on-base elementary schools, the base hospital, and recreation facilities, and that the contamination was confirmed in the early 1980s but not fully disclosed for years afterward.

The Camp Lejeune Justice Act

The Camp Lejeune Justice Act of 2022 (CLJA), passed as part of the broader Honoring our PACT Act, finally created a legal pathway for affected individuals to seek compensation. Eligibility:

• 30+ days at Camp Lejeune between 1953 and 1987
• Includes Marines, family members, and civilian workers
• Diagnosis with a qualifying medical condition within 35 years of last exposure

Qualifying Conditions

The DOJ-Navy Elective Option (EO) — the administrative settlement track — defines two tiers of qualifying conditions:

Tier	Conditions	Settlement Range
Tier 1	Kidney cancer, liver cancer, non-Hodgkin lymphoma, leukemia, bladder cancer	$150,000–$450,000
Tier 2	Multiple myeloma, Parkinson’s disease, kidney disease / end-stage renal disease, systemic sclerosis / scleroderma	$100,000–$400,000
Death cases	Either tier, when claimant has died	Additional $100,000

Settlement amounts within each tier scale with exposure duration. A Marine stationed at Camp Lejeune for the full 1953–1987 period and diagnosed with Tier 1 kidney cancer would be at the high end of the range; a six-month posting with a Tier 2 condition would be near the low end.

Claimants offered an Elective Option settlement typically have 60 days to accept or decline. Declining preserves the right to litigate in federal court, but litigation timelines are far longer than EO settlements.

Where the Numbers Stand

The government reports its progress to the court in periodic status filings in the Eastern District of North Carolina (Case No. 7:23-cv-897) — the most authoritative public accounting available. The money is moving:

Status report	Offered	Paid
Feb 26, 2026	$691.3 million	—
Apr 13, 2026	$794.7 million	$570.7 million
Jun 15, 2026	~$907 million	~$723 million

Payouts rose by roughly $150 million in two months. Against the scale of the claim pool, it barely registers.

The detailed breakdown below is from the April 13, 2026 filing, the most recent one for which a full itemization is public:

Metric	Value (as of Apr 13, 2026)
De-duplicated claims filed with Department of the Navy	408,860
Claims with at least one supporting document	~185,000
Claims settlement-ready (≥3 docs + qualifying EO injury)	~13,000
CLJA lawsuits filed in federal court (E.D.N.C.)	~3,718
Navy administrative-claim EO offers approved	2,686
Navy settlement payments sent	1,766
Bellwether trials held	0

How the Government Got Here

• 1953–1987Contamination period

  Up to one million people are exposed to TCE, PCE, benzene, and vinyl chloride in Camp Lejeune drinking water over roughly 34 years.

• Aug 2022Camp Lejeune Justice Act becomes law

  Passed within the PACT Act, the CLJA creates a federal cause of action and a two-year window to file administrative claims with the Navy.

• Sep 2023Elective Option launched

  DOJ and the Navy roll out the EO administrative settlement track, with tiered payouts from $100,000 to $550,000 based on injury and exposure length.

• Jan 2025Payouts begin in volume

  The government starts clearing settlements at scale; cumulative payments reach roughly $421 million over the following year.

• May 2025Supreme Court declines the jury-trial question

  Certiorari denied in McBrine v. United States. CLJA cases will be decided by a judge, not a jury — removing the threat of a runaway verdict that might have pressured the government toward a global deal.

• Mar 2026Court strikes a government expert

  A magistrate judge throws out the revised reports of a key DOJ expert, ruling the roughly 300 "corrections" were substantive rewrites.

• Jun 15, 2026 — Latest filing~$907M offered, ~$723M paid

  Payments accelerate sharply — yet still under 1% of the 408,860 claims are resolved, and no bellwether trial has been held.

The acceleration of Elective Option approvals is the most positive signal in the whole case: payments have climbed from roughly $421 million in early 2026 to about $723 million by June.

But the math is still sobering. 2,686 approved offers against 408,860 claims is about 0.7%. There is an important nuance the raw rate hides: only about 13,000 claims are actually “settlement-ready” — meaning they carry at least three supporting documents and allege a qualifying EO injury. Measured against that documented subset, the government has made offers on a meaningful share. The gap between 408,860 filed and 13,000 documented is the real bottleneck, and it is not primarily bureaucratic: most claims simply lack the medical-diagnosis and proof-of-presence records the statute requires, for exposures that in many cases ended nearly forty years ago.

Why the Backlog

Several factors explain the gap between filed claims and resolved settlements:

1. Claim documentation requirements. Each claim requires military service records, medical records, exposure dates, and condition diagnosis dates. Reconstructing 30-to-70-year-old paper trails is slow.

2. Federal review staffing. DOJ’s CLJA team has scaled up but remains far smaller than the claim volume.

3. Tier-2 eligibility complexity. Conditions like Parkinson’s disease and systemic sclerosis have longer latency periods and more contested causation than the Tier 1 cancers.

4. Defendant pushback. The Department of the Navy has, in some cases, contested individual claims on causation or exposure-duration grounds, slowing resolution.

5. Choice between EO and litigation. Some claimants whose cases are stronger have chosen to litigate rather than accept EO terms, betting on higher jury awards. The court is working through 25 Track 1 “bellwether” cases to test how juries value the strongest claim types (bladder, kidney, and liver cancer; non-Hodgkin’s lymphoma; leukemia; Parkinson’s) before the broader inventory moves.

What the Bellwether Cases Could Change

The 25 Track 1 bellwether cases in the Eastern District of North Carolina (the federal venue for all CLJA litigation) are meant to set the valuation benchmarks that drive settlement of the wider docket. They have not done so, because none of them has been tried.

That is the single most important fact about the litigation track, and it is routinely obscured. Nearly four years after the CLJA passed, there is no bellwether verdict, no jury award, and no judicial valuation of any Camp Lejeune claim. The cases — five each across bladder cancer, kidney cancer, leukemia, non-Hodgkin lymphoma, and Parkinson’s disease, before Judge James Dever — remain stuck in pretrial motions over expert evidence. The government has said it wants the remaining bellwethers positioned for trial by the end of 2026; no trial date has been set.

Be skeptical of anyone quoting Camp Lejeune “bellwether settlement amounts” to you. Specific figures circulate widely in legal-marketing content — we repeated some of them ourselves before checking — but they do not trace to any court docket or government statement.

Two structural facts shape what the litigation track can deliver:

• There will be no jury. The court held that the CLJA confers no right to a jury trial, and in May 2025 the Supreme Court declined to take up the question. Every case will be decided by a judge. That removes the possibility of an outsized jury verdict — the classic lever plaintiffs use to force a global settlement.
• The government is fighting causation upstream. Rather than let cases reach trial, DOJ is pressing the court to rule that plaintiffs’ expert proof is legally insufficient. If it succeeds, the strongest cases could be resolved without any trial at all.

Both sides have continued working toward a possible global settlement framework with the court’s assistance, but none has been finalized. For most claimants the practical takeaway is unchanged and blunt: the Elective Option remains the faster and, for well-documented claims, often the more valuable path — and over 90% of EO offers that get a response are being accepted.

June 2026: “Science Days” and the Causation Fight

The most important developments of the last month have been about evidence, not dollars. Before any of the Track 1 bellwether cases can go to a jury, the Eastern District of North Carolina must resolve how causation gets proven — and that fight is now coming to a head with the court’s “science days,” the hearings where both sides present the scientific basis for linking the Camp Lejeune contaminants to specific diseases.

Three threads are converging:

• A favorable legal standard for claimants. The Camp Lejeune Justice Act requires plaintiffs only to show that “a causal relationship is at least as likely as not” between the contaminated water and their illness — a far lower bar than the “but-for” standard typical of toxic-tort litigation. How the court applies that standard at science days will ripple through every case in the inventory.

• The government’s push to rule on causation first. The Justice Department has asked the court to revisit its earlier order and decide the government’s “but-for” causation motion before bellwether trials are scheduled — essentially asking the judge to rule now that the plaintiffs’ expert proof is insufficient, rather than letting juries weigh it. If the government prevails, it could short-circuit the strongest cases; if it loses, the bellwethers proceed toward trial.

• Daubert battles over the experts. Both sides filed motions in late 2025 to exclude each other’s expert witnesses, with the government filing more than 30 Daubert motions aimed at knocking out every plaintiff expert across four disease categories — bladder cancer, kidney cancer, Parkinson’s disease, and leukemia / non-Hodgkin lymphoma. In a notable setback for the defense, a federal judge struck reports from a DOJ expert, ruling that her extensive revisions went too far beyond simple corrections to qualify.

The stakes are high precisely because the administrative track remains so backlogged. With only a fraction of the 408,860 filed claims resolved through the Elective Option, the causation framework that science days sets — and the bellwether trials that have still not happened — are what determine whether litigation is a realistic alternative at all for the tens of thousands of claimants the EO has not reached.

Why This Matters for Drinking Water Policy

Camp Lejeune is not just a veterans-affairs story. It is the foundational drinking water contamination case of the modern era. The legal precedent, the documentation standards, the link between specific contaminants and specific health outcomes, and the federal liability framework all draw from Camp Lejeune. The same chemicals at issue — TCE, PCE, benzene, vinyl chloride — are members of the broader VOC (volatile organic compound) family that affects water systems near industrial sites, dry cleaners, and military installations across the country.

For the contaminant chemistry and health effects of the primary culprit, see our TCE (trichloroethylene) profile — including the 2023 JAMA Neurology study that found a 70% higher risk of Parkinson’s disease among the 84,824 Camp Lejeune service members it tracked, which is why Parkinson’s sits on the Elective Option’s qualifying-conditions list at all. The broader VOCs in drinking water profile covers PCE and the rest of the family, and the PFAS contaminant profile offers a parallel forever-chemical legal framework. The Jackson, Mississippi crisis coverage and PFAS regulation rollback provide context on how slow federal water-related litigation moves even when liability is clearly established.

What You Can Do

1. The claim window is closed. The Camp Lejeune Justice Act gave claimants two years to file an administrative claim with the Department of the Navy, and that deadline expired on August 10, 2024. No new claimants can enter the process. If you filed before the deadline and your claim is still pending — which describes the overwhelming majority of the 408,860 filings — the most useful thing you can do is make sure it is documented: only about 13,000 claims carry the three supporting records and qualifying diagnosis needed to be settlement-ready, and that gap, not government foot-dragging, is the single biggest reason claims sit unresolved. Consult an attorney experienced with the act about strengthening an existing claim.

2. For the broader public health implications: The Camp Lejeune contaminants — TCE, PCE, benzene, vinyl chloride — are common at industrial sites and dry cleaners. If you live near such a site, ask your utility for VOC monitoring data or, if on a private well, see how to test your tap water.

3. Filter for VOCs at the tap. Standard activated carbon filters effectively reduce TCE, PCE, and most VOCs. See our best under-sink water filters and best whole-house water filters for certified options.

4. Read the broader regulatory context. Our coverage of state-level PFAS actions and the PFAS regulation rollback covers parallel mass-tort frameworks now playing out for forever chemicals.

How WaterVerge Tracks This

WaterVerge focuses on current EPA-regulated drinking water data — VOC monitoring data is included in city pages where utilities have reported violations or detections under the Phase 1 and Phase 2 SDWA standards. Camp Lejeune as an installation is no longer providing contaminated water (the Marine Corps remediated the systems decades ago), but the legal precedent it has established continues to shape how VOC contamination is handled across the country. Search your city to see current data for your utility.